| |
| |
|
| Insider
Information: |
Proehl Gerald T |
| Relationship: |
President, CEO and Cha... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
149,394 |
|
|
Indirect Shares
|
3,120,953 |
|
|
| Direct
Value |
$29,766 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,270,347 |
|
|
| Total
Value |
$29,766 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Santarus Inc |
SNTS |
President & CEO, Direc... |
2014-01-02 |
0 |
2014-01-02 |
0 |
Premium* |
|
|
Sophiris Bio Inc. |
SPHS |
Director |
2014-09-19 |
10,000 |
2014-09-19 |
0 |
Premium* |
|
|
Auspex Pharmaceuticals, Inc. |
ASPX |
Director |
2015-05-05 |
0 |
2014-09-19 |
0 |
Premium* |
|
|
Qualigen Therapeutics Inc |
QLGN |
Director |
2015-06-24 |
50,000 |
2015-06-24 |
0 |
Premium* |
|
|
Tenax Therapeutics Inc |
TENX |
Director |
2016-11-23 |
29,882 |
2016-11-22 |
0 |
Premium* |
|
|
Dermata Therapeutics, Inc. |
DRMA |
President, CEO and Cha... |
2021-11-23 |
59,512 |
2021-11-23 |
3,120,953 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
52 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
